Kristin Mallon on Menopause-There Is a Hormone for That

Subscribe to Our Podcast In this episode of the Find Your Leadership Confidence Podcast, hosted by Vicki Noethling, Kristin Mallon, CNM, MS, RNC-OB, a renowned board-certified nurse midwife and menopause expert, delves into the topic of menopause and feminine longevity. As the co-founder of Femgevity, a leading telemedicine company focused on menopause, Kristin discusses the importance of personalized healthcare for women, particularly those experiencing the transition into menopause. Addressing deficits in women’s healthcare, Kristin emphasizes the need for specialized care tailored to the individual’s needs, highlighting the role of hormone replacement therapy (HRT) in relieving menopausal symptoms and the associated risks and benefits. She also explores the impact of menopause on mental health, sexual function, and long-term health risks such as heart disease and cognitive decline. Through insightful discussions and expert advice, Kristin provides valuable insights into navigating menopause with confidence and optimizing women’s health and longevity. Tune in to discover how personalized healthcare and specialized expertise are reshaping menopausal healthcare for women’s wellness and vitality. Femgevity is a digital telemedicine company offering women access to personalized, monthly/continuous, and affordable care that addresses their evolving menopause symptoms. Femgevity provides continued medical support, help, and advice beyond just menopause – extending and optimizing feminine health longevity. https://www.femgevityhealth.com/ Connect With Our Guest Website: https://www.femgevityhealth.com/ Facebook: https://www.facebook.com/FemGevity YouTube: https://www.youtube.com/@femgevity Instagram: https://www.instagram.com/femgevity/ TikTok: https://www.tiktok.com/@femgevity Twitter: https://twitter.com/FemGevity The post Kristin Mallon on Menopause-There Is a Hormone for That first appeared on The Find Your Leadership Confidence Podcast with Victoria Noethling.